Rosselkhoznadzor, Russia's agriculture safety watchdog, stated that Russia has registered the world's first COVID-19 vaccine for animals, Reuters news agency reported on Wednesday.
Developed by a unit of Rosselkhoznadzor, this COVID-19 vaccine for animals is named Carnivac-Cov.
Deputy Head of Rosselkhoznadzor, Konstantin Savenkov, was quoted as saying: "The clinical trials of Carnivac-Cov, which started last October, involved dogs, cats, Arctic foxes, minks, foxes and other animals. The results of the trials allow us to conclude that the vaccine is harmless and highly immunogenic as all the vaccinated animals developed antibodies to the coronavirus in 100% of cases."
Immunity lasts for six months after vaccination, but the vaccine developers are continuing to analyse this, Rosselkhoznadzor said, adding that mass production of the vaccine could start as early as April 2021.
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers